Metabolic · Weight Management
Retatrutide Peptide
A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors for advanced metabolic research.
- GLP-1 / GIP / glucagon triple receptor agonist
- 10mg per vial — lyophilized powder
- HPLC verified at 99%+ purity
- Third-party tested · cold-chain shipping
In stock
For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. Not for diagnostic or therapeutic use.
Retatrutide is a novel investigational triple-agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. This tri-receptor approach represents the latest generation of metabolic research compounds, building on the dual-agonist framework established by earlier peptides.
Each vial contains lyophilized retatrutide powder at the selected strength. Reconstitute with bacteriostatic water before use in research applications.
Sequence: Synthetic analog (39 amino acids)
Molecular weight: ~4,600 Da
Appearance: White to off-white lyophilized powder
Solubility: Soluble in bacteriostatic water
Purity: ≥99% (HPLC)
Storage form: Lyophilized
Ships via cold-chain (insulated packaging with ice packs). Standard delivery: 3-5 business days within the continental US. Expedited shipping available at checkout.
Store lyophilized vials at -20°C. Protect from light and moisture. After reconstitution with bacteriostatic water, store at 2-8°C and use within 28 days. Do not freeze reconstituted solution.
Reviews
There are no reviews yet.